Canadian Biotech Market Trend Analysis 2018

Biotechgate presents the annual life science and biotech market trend analysis for Canada. There are currently around thousand biotechnology and around a hundred pharma companies there, excluding subsidiaries of companies headquartered in other countries. The therapeutics sector is remarkably strong and three large financing round has been noted in the last 12 months.  Canadian Biotech … Continue reading Canadian Biotech Market Trend Analysis 2018

Read more

UK Life Sciences Trend Analysis 2018

The UK market remains one of the strongest in Europe. The total value of venture investments in biotech and other life science companies was lower in 2017 than in two previous years, but the number of financing rounds was impressive.

Read more

The Launch of the BioAlberta Life Sciences Database

Zurich, Edmonton January 2018 BioAlberta, a Canadian life sciences industry organization, has recently become a new business partner of Venture Valuation/Biotechgate. BioAlberta gathers a flourishing biotech community comprised of around 170 life sciences companies, government organizations, support service providers, and research & academic institutions, situated across the province. As per the partnership agreement, Venture Valuation … Continue reading The Launch of the BioAlberta Life Sciences Database

Read more

Life Sciences BC – New Canadian Partner for Venture Valuation/Biotechgate

Zurich/Vancouver January 2018 Biotechgate/Venture Valuation announce entering a partnership with Life Sciences British Columbia, a Canadian non-profit organization. The goal of the partnership is to develop and run a database comprised of the life science companies situated in the province of British Columbia. The database will be integrated into the Life Sciences BC website (lifesciencesbc.ca) … Continue reading Life Sciences BC – New Canadian Partner for Venture Valuation/Biotechgate

Read more